Direct to consumer genetic testing: Avoiding a culture war.
James P Evans, Robert C Green
https://pubmed.ncbi.nlm.nih.gov/19606051/Actively Recruiting
Led by National Human Genome Research Institute (NHGRI) · Updated on 2026-11-03
2000
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating rare inherited disorders with unknown genetic causes using advanced genome sequencing techniques. The goal is to identify specific gene mutations responsible for these rare and severe conditions, which may include somatic, de novo, or inherited mutations. This research aims to improve understanding of these disorders and develop best practices for medical care and genetic counseling. Participants, usually recruited as affected individuals along with their parents, undergo genome scale medical sequencing, including exome and genome sequencing. Clinical evaluations and various tests such as X-rays, MRI scans, and consultations may be conducted as needed. Genetic samples like blood, saliva, or skin biopsies are collected to perform the sequencing. Participants have options regarding which genetic results they wish to receive, and results are validated in certified laboratories. Return visits may be offered to discuss findings. During the study, participants receive clinical assessments and genetic testing, with data analyzed to identify relevant gene variants. Information such as clinical photographs and tissue samples may be collected to support diagnosis. The main outcomes measured are the identification and molecular understanding of rare disorders genetic causes. The study involves ongoing monitoring of sequencing results and participants may be contacted for follow-up visits to review findings. The total participation time varies depending on the individual case and testing requirements.
CONDITIONS
Genome Medical Sequencing for Gene Discovery
J
Julie C Sapp
L
Leslie G Biesecker, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Human Genome Research Institute (NHGRI)
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Varies by participant
Participants undergo medical genetics evaluations, clinical examinations, and may have imaging tests such as X-rays or MRIs. Biological samples like blood, saliva, or skin biopsies are collected for genome sequencing.
1 to several visits depending on evaluations needed
Duration - Varies by participant
Sequence data is analyzed to identify genetic variants related to the disorder. Clinically relevant results are validated and returned to participants through return visits or other communication methods.
Return visit offered; alternative result delivery options available
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
James P Evans, Robert C Green
https://pubmed.ncbi.nlm.nih.gov/19606051/T M Marteau, E Dormandy, S Michie
https://pubmed.ncbi.nlm.nih.gov/11359540/Elaine R Mardis
https://pubmed.ncbi.nlm.nih.gov/18576944/National Human Genome Research Institute (NHGRI)
Lead Sponsor